Search

everythinglearnresearchcommunity

for

Search:↓

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

New treatments for PCOS are improving fertility and managing symptoms better.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Medications for PCOS don't seem to raise heart disease risk.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.